Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
289 SAR | +1.26% | +7.76% | +1.76% |
Jun. 03 | Dr. Sulaiman Al Habib Medical Services Secures Final License for Hospital Operations in Saudi Arabia | MT |
May. 19 | Dr. Sulaiman Al Habib Medical Services Declares Q1 Dividend | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 45.94 times its estimated earnings per share for the ongoing year.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.76% | 26.97B | C+ | ||
+24.66% | 88.38B | C+ | ||
-21.76% | 77.56B | B- | ||
-13.50% | 16.57B | B | ||
+3.23% | 15.81B | A- | ||
+77.51% | 13.65B | C- | ||
+76.96% | 13.06B | C+ | ||
+4.72% | 12.61B | A- | ||
+36.67% | 12.56B | B- | ||
+23.02% | 12.55B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 4013 Stock
- Ratings Dr. Sulaiman Al Habib Medical Services Group Company